Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Apr 15, 2019; 11(4): 270-280
Published online Apr 15, 2019. doi: 10.4251/wjgo.v11.i4.270
Published online Apr 15, 2019. doi: 10.4251/wjgo.v11.i4.270
Immune signature | Gene set |
B cells | BACH2, BANK1, BLK, BTLA, CD79A, CD79B, FCRL1, FCRL3, HVCN1, RALGPS2 |
CD8+ T cells | CD8A |
Cytolytic activity | PRF1, GZMA |
HLA | HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DPB2, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DQB2, HLA-DRA, HLA-DRB1, HLA-DRB5, HLA-DRB6, HLA-E, HLA-F, HLA-G, HLA-J |
IFN | DDX4, IFIT1, IFIT2, IFIT3, IRF7, ISG20, MX1, MX2, RSAD2, TNFSF10, GPR146, SELP, AHR |
NK | KLRC1, KLRF1 |
- Citation: He Y, Liu ZX, Jiang ZH, Wang XS. Identification of genomic features associated with immunotherapy response in gastrointestinal cancers. World J Gastrointest Oncol 2019; 11(4): 270-280
- URL: https://www.wjgnet.com/1948-5204/full/v11/i4/270.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i4.270